AI Summary
We reviewed 52 live results for amgevita / yuflyma / hyrimoz (adalimumab biosimilars) and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biosimilar and Immunosuppressant.
Comparison Table
Source: Amgevita
Description
A group of TNF inhibitor monoclonal antibody biosimilars recently approved in Singapore. These are indicated for managing conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
Best for
rheumatoid arthritis patients, Crohn’s disease treatment, psoriatic arthritis care and ulcerative colitis management
Rating
Source: Celltrion USA, Inc.
Description
Yuflyma is a high-concentration (100 mg/mL), citrate-free, and latex-free biosimilar to Humira (adalimumab), classified as a TNF blocker. It is indicated for the treatment of various inflammatory conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. Available in single-dose autoinjectors and prefilled syringes at strengths like 40 mg/0.4 mL and 80 mg/0.8 mL, this biologic medication offers room-temperature stability for up to 31 days, providing flexibility for autoimmune patient care.
Best for
rheumatoid arthritis treatment, citrate-free injection preference, Humira biosimilar seekers, Crohn's disease management and flexible storage needs
Rating
Source: Amgen Inc.
Description
Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes.
Best for
international patients, uveitis treatment, hidradenitis suppurativa care and ankylosing spondylitis patients
Rating
| Compare | Amgevita / Yuflyma / Hyrimoz (Adalimumab Biosimilars) | Yuflyma (adalimumab-aaty) | Amgevita (adalimumab) |
|---|---|---|---|
| Source | Amgevita | Celltrion USA, Inc. | Amgen Inc. |
| Description | A group of TNF inhibitor monoclonal antibody biosimilars recently approved in Singapore. These are indicated for managing conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. | Yuflyma is a high-concentration (100 mg/mL), citrate-free, and latex-free biosimilar to Humira (adalimumab), classified as a TNF blocker. It is indicated for the treatment of various inflammatory conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. Available in single-dose autoinjectors and prefilled syringes at strengths like 40 mg/0.4 mL and 80 mg/0.8 mL, this biologic medication offers room-temperature stability for up to 31 days, providing flexibility for autoimmune patient care. | Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes. |
| Best for | rheumatoid arthritis patients, Crohn’s disease treatment, psoriatic arthritis care and ulcerative colitis management | rheumatoid arthritis treatment, citrate-free injection preference, Humira biosimilar seekers, Crohn's disease management and flexible storage needs | international patients, uveitis treatment, hidradenitis suppurativa care and ankylosing spondylitis patients |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Amgevita / Yuflyma / Hyrimoz (Adalimumab Biosimilars) from Amgevita."
I picked this because Offers modern biologic therapy options for several inflammatory conditions with recent HSA approval for biosimilar use.
Share this search
Related Finds